Physician profile
Gilbert E Marchal
NPI 1861493074
$1,596.79
in general payments reported to CMS, 2019-2025
16 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.51 · 2020: $37.08 · 2021: $83.39 · 2022: $234 · 2023: $560 · 2024: $383 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $566.71 | 2021-2025 | |
| Novo Nordisk INC | $382.69 | 2021-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $111.02 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $90.32 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.31 | 2020-2024 | Jardiance, Synjardy, Tradjenta |
| Glaxosmithkline, LLC. | $79.66 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $60.82 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $48.09 | 2022-2025 | Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $40.98 | 2020-2023 | Breztri, Farxiga |
| Abiomed | $29.33 | 2024 | Impella |
| Verity Pharmaceuticals INC. | $25.61 | 2025 | Tlando |
| Sumitomo Pharma America, INC. | $19.41 | 2025 | Gemtesa |
| Smith+Nephew, INC. | $17.15 | 2025 | Iodosorb Ointment 40g USA, Iodoflex Dressing 5x5g USA, Collagenase Santyl |
| Amarin Pharma, INC. | $16.86 | 2022 | |
| Amgen INC. | $12.66 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Marchal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.